348 related articles for article (PubMed ID: 28754152)
1. Cerebrospinal fluid kynurenine and kynurenic acid concentrations are associated with coma duration and long-term neurocognitive impairment in Ugandan children with cerebral malaria.
Holmberg D; Franzén-Röhl E; Idro R; Opoka RO; Bangirana P; Sellgren CM; Wickström R; Färnert A; Schwieler L; Engberg G; John CC
Malar J; 2017 Jul; 16(1):303. PubMed ID: 28754152
[TBL] [Abstract][Full Text] [Related]
2. Elevated cerebrospinal fluid tumour necrosis factor is associated with acute and long-term neurocognitive impairment in cerebral malaria.
Shabani E; Ouma BJ; Idro R; Bangirana P; Opoka RO; Park GS; Conroy AL; John CC
Parasite Immunol; 2017 Jul; 39(7):. PubMed ID: 28453871
[TBL] [Abstract][Full Text] [Related]
3. Elevated Cerebrospinal Fluid Tau Protein Concentrations on Admission Are Associated With Long-term Neurologic and Cognitive Impairment in Ugandan Children With Cerebral Malaria.
Datta D; Conroy AL; Castelluccio PF; Ssenkusu JM; Park GS; Opoka RO; Bangirana P; Idro R; Saykin AJ; John CC
Clin Infect Dis; 2020 Mar; 70(6):1161-1168. PubMed ID: 31044219
[TBL] [Abstract][Full Text] [Related]
4. Age-related increase of kynurenic acid in human cerebrospinal fluid - IgG and beta2-microglobulin changes.
Kepplinger B; Baran H; Kainz A; Ferraz-Leite H; Newcombe J; Kalina P
Neurosignals; 2005; 14(3):126-35. PubMed ID: 16088227
[TBL] [Abstract][Full Text] [Related]
5. Metabolites of the kynurenine pathway of tryptophan metabolism in the cerebrospinal fluid of Malawian children with malaria.
Medana IM; Day NP; Salahifar-Sabet H; Stocker R; Smythe G; Bwanaisa L; Njobvu A; Kayira K; Turner GD; Taylor TE; Hunt NH
J Infect Dis; 2003 Sep; 188(6):844-9. PubMed ID: 12964115
[TBL] [Abstract][Full Text] [Related]
6. Increased levels of kynurenine and kynurenic acid in the CSF of patients with schizophrenia.
Linderholm KR; Skogh E; Olsson SK; Dahl ML; Holtze M; Engberg G; Samuelsson M; Erhardt S
Schizophr Bull; 2012 May; 38(3):426-32. PubMed ID: 20729465
[TBL] [Abstract][Full Text] [Related]
7. Kynurenine pathway metabolites in cerebrospinal fluid and serum in complex partial seizures.
Heyes MP; Saito K; Devinsky O; Nadi NS
Epilepsia; 1994; 35(2):251-7. PubMed ID: 8156942
[TBL] [Abstract][Full Text] [Related]
8. Quinolinic acid and kynurenine pathway metabolism in inflammatory and non-inflammatory neurological disease.
Heyes MP; Saito K; Crowley JS; Davis LE; Demitrack MA; Der M; Dilling LA; Elia J; Kruesi MJ; Lackner A
Brain; 1992 Oct; 115 ( Pt 5)():1249-73. PubMed ID: 1422788
[TBL] [Abstract][Full Text] [Related]
9. The clinical significance of cerebrospinal fluid levels of kynurenine pathway metabolites and lactate in severe malaria.
Medana IM; Hien TT; Day NP; Phu NH; Mai NT; Chu'ong LV; Chau TT; Taylor A; Salahifar H; Stocker R; Smythe G; Turner GD; Farrar J; White NJ; Hunt NH
J Infect Dis; 2002 Mar; 185(5):650-6. PubMed ID: 11865422
[TBL] [Abstract][Full Text] [Related]
10. Intravenous administration of L-kynurenine to rhesus monkeys: effect on quinolinate and kynurenate levels in serum and cerebrospinal fluid.
Jauch DA; Sethy VH; Weick BG; Chase TN; Schwarcz R
Neuropharmacology; 1993 May; 32(5):467-72. PubMed ID: 8321427
[TBL] [Abstract][Full Text] [Related]
11. Amount of Brain Edema Correlates With Neurologic Recovery in Pediatric Cerebral Malaria.
Kampondeni S; Seydel KB; Zhang B; Small DS; Birbeck GL; Hammond CA; Chilingulo C; Taylor TE; Potchen MJ
Pediatr Infect Dis J; 2020 Apr; 39(4):277-282. PubMed ID: 32168246
[TBL] [Abstract][Full Text] [Related]
12. Decreased cerebrospinal fluid kynurenic acid in epileptic spasms: A biomarker of response to corticosteroids.
Yan J; Kothur K; Innes EA; Han VX; Jones HF; Patel S; Tsang E; Webster R; Gupta S; Troedson C; Menezes MP; Antony J; Ardern-Holmes S; Tantsis E; Mohammad S; Wienholt L; Pires AS; Heng B; Guillemin GJ; Guller A; Gill D; Bandodkar S; Dale RC
EBioMedicine; 2022 Oct; 84():104280. PubMed ID: 36174397
[TBL] [Abstract][Full Text] [Related]
13. High plasma erythropoietin levels are associated with prolonged coma duration and increased mortality in children with cerebral malaria.
Shabani E; Opoka RO; Idro R; Schmidt R; Park GS; Bangirana P; Vercellotti GM; Hodges JS; Widness JA; John CC
Clin Infect Dis; 2015 Jan; 60(1):27-35. PubMed ID: 25228706
[TBL] [Abstract][Full Text] [Related]
14. Association of Plasma Tau With Mortality and Long-term Neurocognitive Impairment in Survivors of Pediatric Cerebral Malaria and Severe Malarial Anemia.
Datta D; Bangirana P; Opoka RO; Conroy AL; Co K; Bond C; Zhao Y; Kawata K; Saykin AJ; John CC
JAMA Netw Open; 2021 Dec; 4(12):e2138515. PubMed ID: 34889945
[TBL] [Abstract][Full Text] [Related]
15. Acute psychotic symptoms in HIV-1 infected patients are associated with increased levels of kynurenic acid in cerebrospinal fluid.
Atlas A; Gisslén M; Nordin C; Lindström L; Schwieler L
Brain Behav Immun; 2007 Jan; 21(1):86-91. PubMed ID: 16603336
[TBL] [Abstract][Full Text] [Related]
16. Polymorphism of Kynurenine Pathway-Related Genes, Kynurenic Acid, and Psychopathological Symptoms in HIV.
Douet V; Tanizaki N; Franke A; Li X; Chang L
J Neuroimmune Pharmacol; 2016 Sep; 11(3):549-61. PubMed ID: 27072370
[TBL] [Abstract][Full Text] [Related]
17. A High-performance Liquid Chromatography Measurement of Kynurenine and Kynurenic Acid: Relating Biochemistry to Cognition and Sleep in Rats.
Baratta AM; Viechweg SS; Mong JA; Pocivavsek A
J Vis Exp; 2018 Aug; (138):. PubMed ID: 30176006
[TBL] [Abstract][Full Text] [Related]
18. Elevated cerebrospinal fluid kynurenic acid levels in patients with tick-borne encephalitis.
Holtze M; Mickiené A; Atlas A; Lindquist L; Schwieler L
J Intern Med; 2012 Oct; 272(4):394-401. PubMed ID: 22443218
[TBL] [Abstract][Full Text] [Related]
19. Cerebrospinal fluid cytokine levels and cognitive impairment in cerebral malaria.
John CC; Panoskaltsis-Mortari A; Opoka RO; Park GS; Orchard PJ; Jurek AM; Idro R; Byarugaba J; Boivin MJ
Am J Trop Med Hyg; 2008 Feb; 78(2):198-205. PubMed ID: 18256412
[TBL] [Abstract][Full Text] [Related]
20. Increased levels of IL-6 in the cerebrospinal fluid of patients with chronic schizophrenia--significance for activation of the kynurenine pathway.
Schwieler L; Larsson MK; Skogh E; Kegel ME; Orhan F; Abdelmoaty S; Finn A; Bhat M; Samuelsson M; Lundberg K; Dahl ML; Sellgren C; Schuppe-Koistinen I; Svensson C; Erhardt S; Engberg G
J Psychiatry Neurosci; 2015 Mar; 40(2):126-33. PubMed ID: 25455350
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
